Advanced Cell Models – Products

AMSBIO has interviewed two extraordinary women in the 3D cell culture and organoid field to mark International Women’s Day on March 8, and World Organoid Research Day on March 22.

MIMETAS announces that it has launched its Adult Stem Cell (ASC)-derived tubular organoids in an assay-ready format.

AMSBIO has published an interview with Professor Ryuji Morizane, a renowned expert in renal research at Harvard Medical School.

CN Bio has announced the commercial launch of the PhysioMimix™ Single-organ Higher Throughput System.

The U.S. Food and Drug Administration and CN Bio have expanded their collaboration for the second time, with new research aiming to evaluate multi-organ MPS and their applications using the PhysioMimix™ Multi-organ System.

CN Bio has announced the appointment of Dr Paul Brooks, formerly the Company’s Chief Business Officer, to the position of CEO with immediate effect.

Generating robust organoids for the lung and gastrointestinal system to recapitulate the complex organ environment remains challenging. Quality growth factors (GFs), such as EGF, FGFs, Noggin, BMP, and RSPO1, are essential in this process. FGF10, HGF, and KGF/FGF7 have been shown to synergistically promote the formation of bronchioalveolar and alveolar organoids. FGF2 and IGF-1 also enhance intestinal organoid plating.

AMSBIO has published an informative handbook for scientists who need to preserve or archive organoids in a research lab.

Molecular Devices, LLC. and HeartBeat.bio AG, a biotech company developing cardiac organoids for drug discovery, have entered into a co-development agreement.

In collaboration with CSEM, 3Brain AG has announced an exciting 3D microchip for their brain-on-chip portfolio.